GSK presents positive data for AREXVY, its respiratory syncytial virus (RSV) vaccine, indicating protection over three RSV seasons

Illness from RSV is considered an infectious disease, usually leading to an infection of the upper respiratory tract but possibly causing lower respiratory tract

Infections caused by the latest variant have symptoms including fever, chills, fatigue, cough, congestion and headache.

Immunization appointments are now open for eligible Albertans. As of Monday (Oct. 7) both COVID-19 and influenza immunization appointments are able to be booked for appointments that are available to the general public starting on October 15.

RSV is a highly contagious virus affecting the respiratory system, especially dangerous for infants, young children, and pregnant women. It leads to symptoms ranging from mild colds to severe respiratory issues.

Respiratory Syncytial Virus RSV is a common respiratory virus primarily affecting young children Here are some remedies to alleviate its symptoms

Dr. Jaunita Mora said the respiratory syncytial virus is the leading cause of infant hospitalizations. Here are the people she said are most vulnerable to the disease.